Page last updated: 2024-08-21

c.i. 42510 and B16 Melanoma

c.i. 42510 has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abe, R; Mori, N; Nishino, K; Suzuki, T; Tanamachi, K; Tanuma, SI; Tsukimoto, M	1

Other Studies

1 other study(ies) available for c.i. 42510 and B16 Melanoma

Article	Year
Radiosensitizing Effect of P2X7 Receptor Antagonist on Melanoma in Vitro and in Vivo. Biological & pharmaceutical bulletin, 2017, Jun-01, Volume: 40, Issue:6 Topics: Animals; Cell Line, Tumor; DNA Damage; DNA Repair; Gamma Rays; Humans; Male; Melanoma, Experimental; Mice, Inbred C57BL; Purinergic P2X Receptor Antagonists; Radiation-Sensitizing Agents; Receptors, Purinergic P2X7; Rosaniline Dyes; Tumor Burden	2017

Article

Year

Radiosensitizing Effect of P2X7 Receptor Antagonist on Melanoma in Vitro and in Vivo.

Biological & pharmaceutical bulletin, 2017, Jun-01, Volume: 40, Issue:6

Topics: Animals; Cell Line, Tumor; DNA Damage; DNA Repair; Gamma Rays; Humans; Male; Melanoma, Experimental; Mice, Inbred C57BL; Purinergic P2X Receptor Antagonists; Radiation-Sensitizing Agents; Receptors, Purinergic P2X7; Rosaniline Dyes; Tumor Burden

2017